Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.49 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.47 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.47 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.47 |
| ▸ | PRKCA | P17252 | 2/20 | 0.44 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 5/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | CTSL | P07711 | 1/20 | 0.38 |
| ▸ | CTSB | P07858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31087985 | 1.00 | ALDH1A1 (0.49) | ALDH1A1PRSS1PRSS2PRSS3PRKCA | |
| SCHEMBL913893 | 0.87 | ALDH1A1 (0.61) | ALDH1A1PRSS1PRSS2PRSS3PRKCA | |
| SCHEMBL7909412 | 0.86 | ALDH1A1 (0.63) | ALDH1A1PRSS1PRSS2PRSS3PRKCA | |
| SCHEMBL8021123 | 0.86 | ALDH1A1 (0.63) | ALDH1A1PRSS1PRSS2PRSS3PRKCA | |
| SCHEMBL1007039 | 0.86 | ALDH1A1 (0.63) | ALDH1A1PRSS1PRSS2PRSS3PRKCA | |
| SCHEMBL9350600 | 0.86 | ALDH1A1 (0.63) | ALDH1A1PRSS1PRSS2PRSS3PRKCA | |
| SCHEMBL5061779 | 0.84 | ALDH1A1 (0.70) | ALDH1A1PRSS1PRSS2PRSS3TSHR | |
| SCHEMBL13676725 | 0.83 | ALDH1A1 (0.59) | ALDH1A1PRSS1PRSS2PRSS3PRKCA | |
| SCHEMBL31039999 | 0.83 | ALDH1A1 (0.59) | ALDH1A1PRSS1PRSS2PRSS3PRKCA | |
| SCHEMBL1523178 | 0.82 | ALDH1A1 (0.71) | ALDH1A1PRSS1PRSS2PRSS3PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111971020-B | Methods for enhancing UVA photoprotection using antioxidants | 莱雅公司 | 2024-01-02 | — | — | CN | claimed |
| EP-1360146-B1 | PROCESS FOR THE PREPARATION OF AQUEOUS SUSPENSIONS OF ANIONIC COLLOIDAL SILICA HAVING A NEUTRAL PH AND APPLICATIONS THEREOF | AZ ELECTRONIC MATERIALS USA (US) | 2012-06-13 | — | — | EP | claimed |
| US-8153107-B2 | Process for the preparation of aqueous suspensions of anionic colloidal silica having a neutral pH and applications thereof | AZ ELECTRONIC MATERIALS USA CORP. (US) | 2012-04-10 | — | — | US | claimed |
| US-20110117035-A1 | PROCESS FOR THE PREPARATION OF AQUEOUS SUSPENSIONS OF ANIONIC COLLOIDAL SILICA HAVING A NEUTRAL PH AND APPLICATIONS THEREOF | MERCK PATENT GMBH (DE) | 2011-05-19 | — | — | US | claimed |
| US-20080159972-A1 | PROCESS FOR THE PREPARATION OF AQUEOUS SUSPENSIONS OF ANIONIC COLLOIDAL SILICA HAVING A NEUTRAL PH AND APPLICATIONS THEREOF | JACQUINOT ERIC | 2008-07-03 | — | — | US | claimed |
| US-20040052901-A1 | Process for the preparation of aqueous suspensions of anionic colloidal silica having a neutral ph and applications thereof | MERCK PATENT GMBH (DE) | 2004-03-18 | — | — | US | claimed |
| CN-120051268-A | Sun protection compositions containing visible light protectants and methods of use | 毛伊岛的马丁医生 | 2025-05-27 | — | — | CN | disclosed |
| EP-3134379-B1 | LIQUID ARYLBENZOYL BENZOIC ACID ESTER DERIVATIVES FOR ENERGY CURABLE COMPOSITIONS | SUN CHEMICAL BV (NL) | 2024-08-28 | — | — | EP | disclosed |
| EP-4398993-A1 | SUNSCREEN COMPOSITION AND METHODS OF PROTECTION FROM ULTRAVIOLET AND VISIBLE LIGHT | Doc Martin's of Maui (US) | 2024-07-17 | — | — | EP | disclosed |
| CN-118234479-A | Sunscreen compositions and methods of protecting against ultraviolet and visible light | 毛伊岛的马丁医生 | 2024-06-21 | — | — | CN | disclosed |
| US-20240058237-A1 | SUNSCREEN COMPOSITION COMPRISING VISIBLE LIGHT PROTECTING AGENTS AND METHODS OF USE | DOC MARTIN'S OF MAUI (US) | 2024-02-22 | — | — | US | disclosed |
| WO-2024035556-A1 | SUNSCREEN COMPOSITION COMPRISING VISIBLE LIGHT PROTECTING AGENTS AND METHODS OF USE | DOC MARTIN'S OF MAUI (US) | 2024-02-15 | — | — | WO | disclosed |
| US-20230416579-A1 | AEROSOL RAW MATERIAL COMPOSITION, AEROSOL COMPOSITION, AND AEROSOL PRODUCT | AGC Inc. (JP) | 2023-12-28 | — | — | US | disclosed |
| US-6946139-B2 | Methods for producing foam from multiphase compositions | CLARIANT GMBH (DE) | 2005-09-20 | — | — | US | disclosed |
| US-20040105825-A1 | Methods for producing foam from multiphase compositions | CLARIANT GMBH | 2004-06-03 | — | — | US | disclosed |
| US-20040052901-A1 | Process for the preparation of aqueous suspensions of anionic colloidal silica having a neutral ph and applications thereof | MERCK PATENT GMBH (DE) | 2004-03-18 | — | — | US | disclosed |
| EP-1360146-A1 | PROCESS FOR THE PREPARATION OF AQUEOUS SUSPENSIONS OF ANIONIC COLLOIDAL SILICA HAVING A NEUTRAL PH AND APPLICATIONS THEREOF | Clariant International Ltd. (CH) | 2003-11-12 | — | — | EP | disclosed |
| EP-1316300-A1 | Use of multiple phase compositions for foaming from foam dispensers | Clariant GmbH (DE) | 2003-06-04 | — | — | EP | disclosed |
| US-20020143203-A1 | Novel indanylidene compounds | SYMRISE GMBH & CO. KG (DE) | 2002-10-03 | — | — | US | disclosed |
| WO-2002055434-A1 | PROCESS FOR THE PREPARATION OF AQUEOUS SUSPENSIONS OF ANIONIC COLLOIDAL SILICA HAVING A NEUTRAL PH AND APPLICATIONS THEREOF | CLARIANT FINANCE (BVI) LIMITED (VG) | 2002-07-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020143203-A1 | Novel indanylidene compounds | CUTA, NISCH, ERCC4 | ALDH1A1 373/4885PRSS1 3624/4885PRSS2 3362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.